Amgen Inc. AMGN
$349.68▲ +0.32% 24H
Super Investor & Insider
3
Fondi che lo detengono
#364
Rank consenso
4.3%
% dei portafogli
$41.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| David Katz · Matrix Asset Advisors | 3.22% | Reduce 3.61% | 99,810 | $35.1M |
| Dodge & Cox · Dodge & Cox | 0% | — | 13,367 | $4.7M |
| Mairs & Power · Mairs & Power | 0.02% | Reduce 10.14% | 4,964 | $1.7M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on innovative medicines addressing serious illnesses in areas such as oncology, inflammation, cardiovascular disease, bone health, nephrology, and neurology. Key products target conditions…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - General
CountryUnited States
Employees31,500
TickerAMGN
Statistics
Market Cap$188.72B
Revenue (TTM)$36.75B
Net Income$7.71B
Net Margin21.0%
EPS$14.23
P/E24.67
P/S5.13
P/B20.79
EV/EBITDA13.45
ROE101.3%
Dividend Yield2.85%
Price$349.68
Data: Twelve Data · Revenue = mcap / P/S